Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
Sponsor: NYU Langone Health
Summary
This pilot study evaluates the feasibility, safety, and preliminary efficacy of home-based 60Hz intermittent light therapy in adults with a major depressive episode (MDE). Participants will be randomized in a 2:1 ratio to receive either active or sham 60Hz intermittent light stimulation for 30 minutes daily (Monday through Friday) over three weeks. The light is delivered through a wearable headset. Clinical assessments will be conducted remotely at baseline, mid-point, post-treatment, and follow-up to measure changes in depressive symptoms.
Official title: A Feasibility Pilot Study of Home-Based Intermittent 60Hz Light Therapy for the Treatment of Depression
Key Details
Gender
All
Age Range
24 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-08-18
Completion Date
2026-03-01
Last Updated
2025-08-26
Healthy Volunteers
No
Interventions
60Hz Intermittent Light Therapy
Intermittent 60 Hz flickering white light delivered via a wearable headset.
Sham Light Therapy
Constant white light delivered via a wearable headset.
Locations (1)
NYU Langone Health
New York, New York, United States